Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus. - Wikidata - thesis-toulmin - TriplyDB

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

http://www.wikidata.org/entity/Q35285768

about

Exploiting tumor epigenetics to improve oncolytic virotherapy Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I Oncolytic immunotherapy: where are we clinically?Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer.Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy.Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis.Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas.Oncolytic adenoviruses: A potent form of tumor immunovirotherapy In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders.Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.Tumor Restrictions to Oncolytic Virus.Role of Gene Therapy in Pancreatic Cancer-A Review.MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

P2860

Q21131237-56DEA2BB-86C4-4F01-B64C-FD335ED30B56 Q26767209-A805D71C-B94C-4556-9234-D570CF83A563 Q26767212-EA5E48E8-2E53-4E05-A3AC-20847FC5ADBD Q27307734-C541FBC6-9FF7-493C-9FA3-0ACFD7FC3F2A Q34405325-88A8EE80-BE4D-45B8-B438-9ECF2B59161C Q36220624-42660F27-A734-4126-8E64-211BD92B8C05 Q36538951-5119CC75-9EB6-4E66-B304-1E2B9C08E937 Q36582785-BBE4FE27-B42B-4F26-8984-163B323BCE5C Q36664229-A5390EF9-07DC-4D37-8E36-91F29E2D0910 Q37718529-78D6BC8D-54F8-473E-BE73-0C0D8E0F5BCC Q37977063-E67A757B-581F-41D2-ACA8-D3F52E57F9EF Q38295771-A7B51888-BC00-47E3-9A25-20AB382FB699 Q38793802-713717D3-D1FA-40A1-8F32-1844E48F1E51 Q38850871-21580F99-0998-4C8C-A99F-4EBCB1D68036 Q39109430-B19C7A92-A753-4E16-BF36-FC5747DDC9A6 Q39213379-31049C26-1891-42FE-A75F-25106B2E4253 Q40086745-21462F92-F98D-4363-8413-F9088C7A05D1 Q41474598-6D1076C9-A093-4CD0-9C29-2189245A2923 Q42254679-67CFEDCB-2C84-49B4-85D0-EB2E8353C663 Q49787495-AC743B4E-743B-44D2-B6B6-F7BC41159B78 Q51846287-9BB13A96-8A52-4DCE-BCD9-D06A14FD1177 Q52610258-EFCDD246-8CF5-4775-948A-4E2D4BA06061 Q53122691-54EFE6E7-CFE4-4A69-90EB-5B844E967C54 Q55510561-EA289963-83BA-4D7C-AF61-33A87F5B50EA

P2860

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

http://www.wikidata.org/entity/Q35285768

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@ast

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@en

type

label

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@ast

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@en

prefLabel

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@ast

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@en

P1433

Q35285768-3BE092C8-AEA1-4161-ACD6-882762417A67

P1476

Q35285768-5A9DBBB1-C05F-4366-A702-B9413F6DA327

P2093

Q35285768-0D73CA61-D235-41FA-9C7C-7510942CF6CD

Q35285768-10F9C1F6-A92B-440D-9957-672674177F32

Q35285768-23BF85FE-9D19-4455-8EAD-F5CB85673E17

Q35285768-41BEDDEA-F92E-4EBA-A3FE-5BC6F9750710

Q35285768-4B1B6574-F373-4917-A99A-A577FDBB6B42

Q35285768-AE8CF087-5080-467C-93EE-F2145AA62CCB

Q35285768-B51A0B6F-35D2-4463-AF8A-CFB76DDB970C

Q35285768-B9805667-C47E-4D1B-9AD7-FFE1F44AA23B

Q35285768-C9327CE4-57CB-4B04-8EA5-2646F6089631

Q35285768-DEF95808-248A-4F42-B226-06E84C82BC62

P2860

Q35285768-13718121-7975-4B40-BE16-876756560529

Q35285768-13E8FB4D-1D23-407B-942A-0359942E6C2B

Q35285768-1ADA4DF9-0EB0-43AF-998C-378D91B6F2B5

Q35285768-1FF16F7B-47CB-49B9-994A-7A50D48AEB70

Q35285768-2478DD7B-8702-4F5F-83C5-41EC668CEFCC

Q35285768-25AA82B3-E008-4114-9BFA-9D8548D9E6E9

Q35285768-382D70FE-A249-41C5-8AC2-0CF8F977AA51

Q35285768-38CB55F1-EA9E-4BCD-97B6-8F8A6C1895F6

Q35285768-48A705C1-924A-47DF-9ACD-846C569B7340

Q35285768-5548E5E1-68DE-44FA-8250-AF3325176D20

P304

Q35285768-774C7CD2-5632-42B9-8C0C-D1896121811E

P31

Q35285768-EBC173F2-60F3-4611-962C-89E311123490

P356

Q35285768-D6B46BAF-D3E6-4B57-96F5-C1CB57D7F020

P433

Q35285768-C5113522-69CC-4A65-899D-80872E3A2B68

P478

Q35285768-19677CB9-0692-4411-AF32-5FCC54BF5074

P50

Q35285768-014A9626-5130-4940-A804-207362821038

Q35285768-229DEC86-4574-4CB3-AB6A-B2CE3B69B945

Q35285768-89DD0D30-8043-4F57-9816-E2ACEB86ABBE

Q35285768-E0F06D65-C5B4-413F-AAE2-93F934BFB7AD

Q35285768-F8930896-C622-4A61-BA05-244FB3B1B94F

P577

Q35285768-6BD834D8-3744-493C-841C-95217E3C112D

P5875

Q35285768-59C0A969-1B9D-49D5-BE18-C6ECDBBDC360

P698

Q35285768-744606AE-E551-4DA5-BFC6-DD486F65587F

P921

Q35285768-4CA82A8E-2A0D-475C-BB0D-769B6E981DF3

Q35285768-99B20234-9C0D-4878-8D07-CCF8C9F98981

P932

Q35285768-A0DAE332-D305-46BB-89E0-47FC5465D262

P356

P1433

Molecular Therapy

P1476

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.

@en

P2093

Daniela Marzioni

http://www.w3.org/2001/XMLSchema#string

Ilkka Liikanen

http://www.w3.org/2001/XMLSchema#string

João D Dias

http://www.w3.org/2001/XMLSchema#string

Laura Ahtiainen

http://www.w3.org/2001/XMLSchema#string

Marco Colombatti

http://www.w3.org/2001/XMLSchema#string

Mari Raki

http://www.w3.org/2001/XMLSchema#string

Otto Hemminki

http://www.w3.org/2001/XMLSchema#string

Sari Pesonen

http://www.w3.org/2001/XMLSchema#string

Vincenzo Cerullo

http://www.w3.org/2001/XMLSchema#string

Vladia Monsurrò

http://www.w3.org/2001/XMLSchema#string

P2860

KEGG for representation and analysis of molecular networks involving diseases and drugs

Interferon-inducible antiviral effectors

Summaries of Affymetrix GeneChip probe level data

Progress and prospects: immune responses to viral vectors

Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

Pre-processing of microarray data and analysis of differential expression.

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors.

A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers.

P304

1858-1866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.144

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Akseli Hemminki

Tanja Hakkarainen

Sophie Escutenaire

P577

2011-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51523926

http://www.w3.org/2001/XMLSchema#string

P698

21792178

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3188743

http://www.w3.org/2001/XMLSchema#string